English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 8 November 2024, 20:23 HKT/SGT
Share:
ITC's Final Decision Confirms Innoscience's Customers Remain Unaffected by the Innoscience-EPC Patent Row
- Finds No Infringement of the '508 Patent
- and Paves the Way for Designing Around the Remaining '294 Patent Currently Stands Challenged as Invalid at USPTO

HONG KONG, Nov 8, 2024 - (ACN Newswire) - Innoscience Technology, a company founded to create a global energy ecosystem based on high-performance, low-cost, gallium-nitride-on-silicon (GaN-on-Si) power solutions, announced today that the U.S. International Trade Commission’s (“ITC”) November 7, 2024 final determination has confirmed the ability of Innoscience’s customers to import their products into U.S. remain unaffected by the ongoing patent dispute between Innoscience and Efficient Power Conversion Corporation (“EPC”).

In May last year, EPC launched a lawsuit against Innoscience at the ITC, falsely alleging infringement of EPC’s ’508 and ’294 patents. Following an administrative law judge’s initial determination in the past July finding no infringement of claim 1 (the only asserted claim) of the ’508 patent, the latest ITC final determination once again affirmed no violation as to this patent—a huge success for Innoscience.

The final determination, however, affirmed the part of the judge’s initial determination that found violation as to claims 2 and 3 the ’294 patent. The ITC hence has determined to issue a limited exclusion order prohibiting importation of certain accused Innoscience chips. Innoscience disagrees with and will appeal this ruling. This is at least because the ‘294 patent is invalid. Indeed, the U.S Patent and Trademark Office (“USPTO”) instituted an inter partes review (“IPR”) challenging all claims of the ’294 patent under four different grounds and has agreed with Innoscience’s invalidity arguments. The ’294 IPR decision will issue in March 2025.

Innoscience also notes it is established U.S. law that the limited exclusion order does not prohibit Innoscience’s customers from importing end products that use the accused chips. Moreover, since the final decision clarified the meaning of the claim term “compensated GaN layer,” which is at the center of the dispute surrounding the ’294 patent, it has provided clear guidance for Innoscience to design around the ’294 patent by avoiding use of the “compensated GaN layer.” Innoscience already has the design around in place and will release the new products soon.  

Accordingly, the EPC litigation shall have no impact on Innoscience’s customers. Moreover, Innoscience will continue to solve the dispute with EPC through appeals in court and invalidity challenges at the USPTO, and is confident that it will achieve a final complete victory. 



Topic: Press release summary Sectors: Electronics
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries  
Mar 24, 2026 15:11 HKT/SGT
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders  
Mar 24, 2026 15:03 HKT/SGT
Dida Inc. (02559.HK) Announced 2025 Annual Results, RMB 138 Million Adjusted Net Profit  
Mar 24, 2026 14:23 HKT/SGT
Fujitsu and Umios conduct joint pilot project for electronic traceability system to visualize seafood distribution  
Tuesday, March 24, 2026 1:01:00 PM
TINGYI (CAYMAN ISLANDS) HOLDING CORP. Business Momentum Sustained in 2025, United for a New Journey, with GPM Rising to 34.8%, Profit Attributable to Shareholders Up 20.5% YoY  
Mar 24, 2026 10:31 HKT/SGT
International Career Institute Marks 20 Years with 100 Scholarships to Support Flexible Online Study  
Mar 24, 2026 07:29 HKT/SGT
Doubleview Gold Clarifies Preliminary Economic Assessment Results for the Hat Project; Updated Scenario B NPV Increased to C$7.27 Billion  
Mar 24, 2026 04:59 HKT/SGT
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share  
Mar 23, 2026 20:51 HKT/SGT
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe  
Mar 23, 2026 20:29 HKT/SGT
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 23, 2026 18:59 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575